These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
627 related items for PubMed ID: 29309155
21. Amorphous-Amorphous Phase Separation in API/Polymer Formulations. Luebbert C, Huxoll F, Sadowski G. Molecules; 2017 Feb 15; 22(2):. PubMed ID: 28212300 [Abstract] [Full Text] [Related]
27. Hydroxypropyl cellulose stabilizes amorphous solid dispersions of the poorly water soluble drug felodipine. Sarode AL, Malekar SA, Cote C, Worthen DR. Carbohydr Polym; 2014 Nov 04; 112():512-9. PubMed ID: 25129775 [Abstract] [Full Text] [Related]
28. Drug Release and Nanodroplet Formation from Amorphous Solid Dispersions: Insight into the Roles of Drug Physicochemical Properties and Polymer Selection. Yang R, Mann AKP, Van Duong T, Ormes JD, Okoh GA, Hermans A, Taylor LS. Mol Pharm; 2021 May 03; 18(5):2066-2081. PubMed ID: 33784104 [Abstract] [Full Text] [Related]
29. Phase Behavior of Ritonavir Amorphous Solid Dispersions during Hydration and Dissolution. Purohit HS, Taylor LS. Pharm Res; 2017 Dec 03; 34(12):2842-2861. PubMed ID: 28956218 [Abstract] [Full Text] [Related]
32. Five-Stage Approach for a Systematic Screening and Development of Etravirine Amorphous Solid Dispersions by Hot-Melt Extrusion. Simões MF, Pereira A, Cardoso S, Cadonau S, Werner K, Pinto RMA, Simões S. Mol Pharm; 2020 Feb 03; 17(2):554-568. PubMed ID: 31774685 [Abstract] [Full Text] [Related]
33. Investigating phase separation in amorphous solid dispersions via Raman mapping. Luebbert C, Klanke C, Sadowski G. Int J Pharm; 2018 Jan 15; 535(1-2):245-252. PubMed ID: 29133204 [Abstract] [Full Text] [Related]
34. Barrier coated drug layered particles for enhanced performance of amorphous solid dispersion dosage form. Puri V, Dantuluri AK, Bansal AK. J Pharm Sci; 2012 Jan 15; 101(1):342-53. PubMed ID: 21935949 [Abstract] [Full Text] [Related]
35. Spray drying ternary amorphous solid dispersions of ibuprofen - An investigation into critical formulation and processing parameters. Ziaee A, Albadarin AB, Padrela L, Faucher A, O'Reilly E, Walker G. Eur J Pharm Biopharm; 2017 Nov 15; 120():43-51. PubMed ID: 28822874 [Abstract] [Full Text] [Related]
36. Influence of Glass Forming Ability on the Physical Stability of Supersaturated Amorphous Solid Dispersions. Blaabjerg LI, Bulduk B, Lindenberg E, Löbmann K, Rades T, Grohganz H. J Pharm Sci; 2019 Aug 15; 108(8):2561-2569. PubMed ID: 30878513 [Abstract] [Full Text] [Related]
37. Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization. Hörmann TR, Jäger N, Funke A, Mürb RK, Khinast JG, Paudel A. Int J Pharm; 2018 Dec 20; 553(1-2):408-421. PubMed ID: 30326284 [Abstract] [Full Text] [Related]
38. An investigation into the role of polymeric carriers on crystal growth within amorphous solid dispersion systems. Tian Y, Jones DS, Andrews GP. Mol Pharm; 2015 Apr 06; 12(4):1180-92. PubMed ID: 25692314 [Abstract] [Full Text] [Related]
39. Congruent Release of Drug and Polymer from Amorphous Solid Dispersions: Insights into the Role of Drug-Polymer Hydrogen Bonding, Surface Crystallization, and Glass Transition. Saboo S, Kestur US, Flaherty DP, Taylor LS. Mol Pharm; 2020 Apr 06; 17(4):1261-1275. PubMed ID: 32134677 [Abstract] [Full Text] [Related]
40. Thermodynamic phase behavior of API/polymer solid dispersions. Prudic A, Ji Y, Sadowski G. Mol Pharm; 2014 Jul 07; 11(7):2294-304. PubMed ID: 24870944 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]